Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 12/4/2016 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Nikolaj Sorensen?

Nikolaj Sorensen

President

Orexo AB

HQ Phone:  +46 18 780 88 00

Direct Phone: +46 ** *** ** **direct phone

Email: n***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Orexo AB

P.O. Box 303

Uppsala, Uppsala,SE-751 05

Sweden

Company Description

Orexo is a specialty pharmaceutical company commercializing its proprietary product Zubsolv for treatment of opioid dependence in the US. Zubsolv is an advanced formulation of buprenorphine and naloxone using Orexo's unique knowledge and expertise in sublingua...more

Background Information

Employment History

European and Canada Marketing Director Lyrica

Pfizer Inc


Consultant

The Boston Consulting Group Inc


Affiliations

The Swedish-American Chamber of Commerce , Inc.

Board Member


LIF

Board Member


Education

Master of Science

Business and Economics


Web References(140 Total References)


US-N8V-4CHN-C IT Guy - Page 2 - Suboxone & Buprenorphine

subotex.com [cached]

Nikolaj Sorensen, Chief Executive Officer of Orexo, noted "We know a main barrier for DATA2000 certified physicians to start treating opioid dependent...


www.swisslifesciences.com

Nikolaj Sørensen, President and CEO of Orexo AB, will present the business, focusing on the driving forces behind the global opioid addiction treatment market, the development of Zubsolv® in the US and the progress towards launching in the rest of the world.
An overview will also be given of Orexo's pipeline of innovative product development programs and the company's recent strong financial development. In addition a fresh interview with Nikolaj Sørensen is available at www.orexo.com.


Management - Orexo

www.orexo.com [cached]

Nikolaj Sørensen (born 1972)


Orexo Annual Report 2012

www.orexo.com [cached]

1. Nikolaj Sørensen (b. 1972)


Orexo Receives USD 2.5 Million Milestone Payment From AstraZeneca as OX-CLI Advances Into Clinical

www.prnewswire.com [cached]

Nikolaj Sørensen, President and CEO of Orexo AB (publ.), said: "I am very pleased with the progress in the OX-CLI project and the efforts from AstraZeneca to advance this important project.
Nikolaj Sørensen President and CEO Tel: +46-(0)-18-780-88-00 E-mail: ir@orexo.com


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory